We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

38 hedge funds and large institutions have $14.7M invested in Accelerate Diagnostics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less capital invested

Capital invested by funds: $18M → $14.7M (-$3.33M)

24% less funds holding

Funds holding: 50 → 38 (-12)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

53% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 19

Holders
38
Holders Change
-12
Holders Change %
-24%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
12
Closed
19
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$14K

Top Buyers

Rank Fund Capital Flow
1
CC
Cannell & Co
New York
+$772K
2
GAM
Griffin Asset Management
New York
+$613K
3
CI
Chartist Inc
California
+$451K
4
TWA
TCI Wealth Advisors
Arizona
+$395K
5
Northern Trust
Northern Trust
Illinois
+$237K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$99.7K
2
OIM
Oracle Investment Management
Connecticut
-$97.8K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$52K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$44.5K
5
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$31.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
HGERS
26
Householder Group Estate & Retirement Specialist
Arizona
$4.6K +$5.38K +800 New
TRCT
27
Tower Research Capital (TRC)
New York
$2.96K +$3.46K +515 New
SPIA
28
Steward Partners Investment Advisory
New York
$2.36K – – –
Carson Wealth (CWM LLC)
29
Carson Wealth (CWM LLC)
Nebraska
$2K – – –
Wells Fargo
30
Wells Fargo
California
$1.29K -$81 -12 -5%
BCWM
31
Bartlett & Co Wealth Management
Ohio
$1.15K – – –
BC
32
Bartlett & Co
Ohio
$1K – – –
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$942 – – –
GIA
34
GHP Investment Advisors
Colorado
$588 +$606 +90 +900%
PMFA
35
Plante Moran Financial Advisors
Michigan
$575 – – –
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
$201 +$235 +35 New
JP Morgan Chase
37
JP Morgan Chase
New York
$46 +$40 +6 +300%
PCA
38
Providence Capital Advisors
North Carolina
$23 -$7 -1 -20%
Millennium Management
39
Millennium Management
New York
– -$99.7K -12,314 Closed
T. Rowe Price Associates
40
T. Rowe Price Associates
Maryland
– -$52K -6,390 Closed
CIBC Private Wealth Group
41
CIBC Private Wealth Group
Georgia
– -$31.9K -3,942 Closed
Charles Schwab
42
Charles Schwab
California
– -$24.7K -3,051 Closed
Baird Financial Group
43
Baird Financial Group
Wisconsin
– -$24.3K -3,003 Closed
Mariner
44
Mariner
Kansas
– -$23.5K -2,907 Closed
SWM
45
SeaCrest Wealth Management
New York
– -$21.8K -2,688 Closed
Cambridge Investment Research Advisors
46
Cambridge Investment Research Advisors
Iowa
– -$20K -2,452 Closed
GT
47
Glenmede Trust
Pennsylvania
– -$14K -2,000 Closed
RJA
48
Raymond James & Associates
Florida
– -$13.8K -1,700 Closed
Bank of New York Mellon
49
Bank of New York Mellon
New York
– -$11.6K -1,438 Closed
GWM
50
Greenwich Wealth Management
Connecticut
– -$9K -1,080 Closed
1
2
3

AXDX Hedge Fund Activity: Q3 2023 in Review

38 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2023, worth a combined $14.7M — down 18% from $18M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of AXDX and 9 opened new positions — a net loss of 10 holders — while 12 trimmed existing stakes and 6 added.

The largest buyer was Cannell & Co, opening a new position worth an estimated $772K. The largest seller was Millennium Management, exiting entirely with an estimated $99.7K sold.

  • 38 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2023, down from 50 in Q2 2023.
  • Funds reported $14.7M of Accelerate Diagnostics stock for Q3 2023, down 18% quarter-over-quarter.
  • 9 funds opened new Accelerate Diagnostics positions in Q3 2023 and 19 closed out, a net change of -10 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2023 was Cannell & Co, an estimated $772K added.
  • The largest Accelerate Diagnostics seller in Q3 2023 was Millennium Management, an estimated $99.7K sold.

Based on aggregated 13F filings for Q3 2023.